-
Interviews with leading Life Sciences companies: Sonire Therapeutics
Sonire Therapeutics has commenced a randomized Phase 2 study for the treatment of unresectable pancreatic … Read more
-
Venture Valuation/Biotechgate and AdvaMed Team Up to Drive MedTech Industry Growth
Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business … Read more
-
RESI Conference June 2023 – Company Valuation for Fundraising & Financing and M&A trends
RESI, Boston, June 2023, 32 pages Presentation
-
Venture Valuation and Biotechgate to participate in the 2023 BIO International Convention in Boston
ZURICH, Switzerland, May 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation … Read more
-
Interviews with leading Life Sciences companies: J-Pharma
J-Pharma is a frontrunner in developing inhibitors of L-type amino acid transporter for treating advanced … Read more
-
Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory
Media Release Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory Zurich, Switzerland and Paris, … Read more
-
Interviews with leading Life Sciences companies: Aipore
Aipore is developing AI-enabled solid-state nanospore sensor technology that can detect SARS-CoV2 coronavirus in saliva … Read more
-
Interviews with leading Life Sciences companies: Varinos Inc.
Varinos commercialized the world’s first highly accurate endometrial microbiome testing service by applying next-generation sequencing. … Read more
-
The World’s First Drug Discovery Platform Using Quantum Computing – POLARISqb
Founded in 2020 and winners of the XY Factor competition at Biotechgate Digital Partnering February … Read more
-
New treatment modality for amyloidosis related diseases – Vermilion Therapeutics
Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. … Read more